Pharmaceutical Drug Product Development
Addressing the increasing pressure on pharmaceutical companies to bring clinical candidates through their pipeline faster and with greater efficiency, we provide expert pharmaceutical drug product development and manufacturing solutions. Working in true partnership we will support your solid oral dose product development programme through experience, expertise, and efficiency.
Operating from state-of-the-art, custom designed facilities, our scientists can develop your clinical candidates into optimum formulations and manufacture solid oral dose products for all stages of clinical trials.
From developing a fit-for-purpose formulation for First-in-Human trials, to scaling up for late phase trials, registration and ultimately scaling up for ongoing commercial supply, our pharmaceutical drug product development solutions are tailored to meet your needs.
Our purpose-built facilities in Craigavon and at the Charnwood Campus, UK provide solid oral dose drug product development, manufacturing and analytical testing capacity, ensuring we can meet your future pharmaceutical development and manufacturing needs.
Early Phase Pharmaceutical Development
Non-GMP Development
Potent Processing and Manufacture
Early Phase Scalability
Late Phase Pharmaceutical Development
Late Phase Quality by Design
Late Phase Scalability
Flexible GMP Manufacturing Capacity
CMC Services
Post-Brexit: The Almac Advantage – find out more about our unique, unfettered and flexible access to UK, Europe and beyond
Related Resources
Brochure
Pharmaceutical Development
Brochure
Almac Pharma Services
Case Study